Paper Details

Paper Title

Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment.

Paper Journal Title

Mol Cancer Res

Paper Citation Count

Paper Publication Year

2022

Bio Mention

AA, AKT, AKT1, AR, AR variants, AURKA, AURKB, Aurora kinase, CDK11B, CYP19A1, Castrate-Resistant Prostate Cancer, HSD17B11, MTOR, MYC, MYC regulated genes, PDCD1, PI3K, Patients, Prednisone, Prostate Cancer, RNA, SCN, TGFBR3, TOP2A, Wnt, abiraterone acetate, androgen, androgen processing genes, mCRPC, metastatic castration-resistant prostate cancer, patients, prednisone, target genes, topoisomerase

Mesh Descriptor

Author Name	Affiliation
Hugues Sicotte	Mayo Clinic
Vipul Bhargava
Alan H Bryce	Mayo Clinic
Richard M Weinshilboum	Mayo Clinic
Liewei Wang	Mayo Clinic

1 - 5

Paper Details

Column Actions

Datasets